The latest closing stock price for CytomX Therapeutics as of March 28, 2025 is 0.63.
An investor who bought $1,000 worth of CytomX Therapeutics stock at the IPO in 2015 would have $-951 today, roughly -1 times their original investment - a -28.52% compound annual growth rate over 9 years.
The all-time high CytomX Therapeutics stock closing price was 34.22 on March 12, 2018.
The CytomX Therapeutics 52-week high stock price is 5.85, which is 828.6% above the current share price.
The CytomX Therapeutics 52-week low stock price is 0.56, which is 11.1% below the current share price.
The average CytomX Therapeutics stock price for the last 52 weeks is 1.29.
An investor who bought $1,000 worth of CytomX Therapeutics stock at the IPO in 2015 would have $-951 today, roughly -1 times their original investment - a -28.52% compound annual growth rate over 9 years.
The all-time high CytomX Therapeutics stock closing price was 34.22 on March 12, 2018.
The CytomX Therapeutics 52-week high stock price is 5.85, which is 828.6% above the current share price.
The CytomX Therapeutics 52-week low stock price is 0.56, which is 11.1% below the current share price.
The average CytomX Therapeutics stock price for the last 52 weeks is 1.29.